Cheaper drug prices the destination in China healthcare reform map
12 April 2016
China's Premier Li Keqiang said the State Council has mapped out medical system reforms for this year with plans to buy drugs for public hospitals via a central system and then compare prices to pharmacies and other outlets for transparency.
Can the cancer moonshot help cure Big Pharma's big bad reputation?
12 April 2016
Vice President Joe Biden's cancer moonshot initiative has been celebrated for its exuberance and chided for its too-small budget. But InTouch Solutions CEO Faruk Capan thinks there's a less obvious reason pharma should get on board with the idea: It might help salvage the industry's floundering reputation.
Advice for biopharmas in China? Mind the gap
12 April 2016
In China, meeting the country's unmet medical needs is a frequent topic of discussion. For biopharmas, that can mean filling the substantial gap between which drugs are available in developed markets and which are available for patients here.
Tobira Therapeutics and Dong-A ST Enter Into License Agreements for Evogliptin and Cenicriviroc
11 April 2016
Tobira Therapeutics, Inc. (NASDAQ:TBRA) and Dong-A ST Co., Ltd. (170900: Korea SE), today announced that the companies have entered into two separate licensing agreements. Tobira has acquired exclusive rights to develop and market evogliptin in combination with cenicriviroc (CVC) and as a single agent in the United States, Canada, Europe and Australia for all therapeutic indications.
The biotech cycle: Some views from the top
11 April 2016
After its fall meeting in Germany, EBD Group's BIO-Europe spring partnering meeting normally heads south to the warmer climes of Spain or Italy. This year, however, it headed north to Stockholm, where spring is still more a suggestion than a reality. The relative chill that greeted delegates arriving in Sweden's capital could be a metaphor for what's ahead for the biotechnology sector in the coming year.
Building a wall to keep companies in
11 April 2016
They may not realize it, but many Americans woke up this morning with their retirement portfolio worth less than it was a week ago. And it could be worth less tomorrow and even a year or a decade from now than it would have been – all because of Monday’s unilateral decision by the Department of Treasury to build an even higher wall, at the expense of investors, to keep U.S. businesses from moving out of the country.
Experts worry insulin getting too expensive for many in U.S. and worldwide
11 April 2016
Drugmakers have made great strides coming up with new treatments for diabetes as the disease gallops across the globe. But healthcare professionals are concerned that hormone insulin meds, often the key treatment, are getting too costly for many patients, even in the U.S. In developing countries, they say engineered insulin is automatically out of reach of many people while supplies of older, but cheaper, human insulin are becoming scarce.
Ascension Ventures' Matt Hermann on VC and healthtech
08 April 2016
We recently sat down with Ascension Ventures senior managing director Matt Hermann to talk about his firm's unique approach to investing and how VC investment in the healthcare sector has changed in recent years. Wonder what's next for the industry?
Up up and away: 2015 pharma ad spending ties decade-old record
08 April 2016
It's a tie. Pharma advertisers spent $5.4 billion in 2015, tying the previous industry record set in 2006, according to new data from Kantar Media. That's an increase of 19% over the category's $4.53 billion tally for 2014.
Nanoparticle 'cluster-bomb' penetrates tumors to reduce chemo doses
08 April 2016
A team of scientists from the U.S. and China have devised a type of nanoparticle containing yet more nanoparticles, together which form a "cluster-bomb" to improve tumor penetration.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024
CRISPR technologies fuelling haematological innovations
17 April 2024
17 April 2024